Changes in blood dendritic cell counts in relation to type of coronary artery disease and brachial endothelial cell function

Coronary Artery Disease

Volumn 21, Issue 2, 2010, Pages 87-96

  Van Vré, Emily A ^a   Van Brussel, Ilse ^a   De Beeck, Ken Op ^a   Hoymans, Vicky Y ^b   Vrints, Christiaan J ^a   Bult, Hidde ^a   Bosmans, Johan M ^a,b  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Blood dendritic cells; Coronary artery disease; Endothelial cell function; Flow cytometry; Flow mediated vasodilatation; Myeloid dendritic cells; Plasmacytoid dendritic cells

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CELL COUNT; BRACHIAL ARTERY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENDRITIC CELL; ENDOTHELIUM CELL; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THORAX PAIN;

ADRENERGIC BETA-ANTAGONISTS; AGED; BRACHIAL ARTERY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOPHENOTYPING; INFLAMMATION MEDIATORS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VASODILATION;

EID: 77249133714     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283368c0e     Document Type: Article

References (27)

1. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165:6037-6046.
2. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5:1219-1226.
3. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity 2007; 26:741-750.
4. Bobryshev YV. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur Heart J 2005; 26:1700-1704.
5. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004; 176:101-110.
6. Van Vré EA, Hoymans VY, Bult H, Lenjou M, Van Bockstaele DR, Vrints CJ, et al. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron Artery Dis 2006; 17:243-248.
7. Yilmaz A,Weber J, Cicha I, Stumpf C, Klein M, Raithel D, et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol 2006; 48:70-80.
8. Shi H, Ge J, Fang W, Yao K, Sun A, Huang R, et al. Peripheral-blood dendritic cells in men with coronary heart disease. Am J Cardiol 2007; 100:593-597.
9. Anderson TJ. Prognostic significance of brachial flow-mediated vasodilation. Circulation 2007; 115:2373-2375.
10. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004; 43:616-623.
11. Yilmaz A, Schaller T, Cicha I, Altendorf R, Stumpf C, Klinghammer L, et al. Predictive value of the decrease in circulating dendritic cell precursors in stable coronary artery disease. Clin Sci (Lond) 2009; 116:353-363.
12. Kofler S, Schlichting C, Jankl S, Nickel T,Weis M. Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion. Atherosclerosis 2007; 197:105-110.
13. Von Haehling S, Schefold JC, Jankowska E, Doehner W, Springer J, Strohschein K, et al. Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure. PLoS ONE 2009; 4:e6411.
14. Niessner A, Sato K, Chaikof EL, Colmegna I, Goronzy JJ, Weyand CM. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation 2006; 114:2482-2489.
15. Weis M, Schlichting CL, Engleman EG, Cooke JP. Endothelial determinants of dendritic cell adhesion and migration: new implications for vascular diseases. Arterioscler Thromb Vasc Biol 2002; 22:1817-1823.
16. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26:1235-1241.
17. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82:1535-1538.
18. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flowmediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115:2390-2397.
19. Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24:1997-2008.
20. Gunn MD. Chemokine mediated control of dendritic cell migration and function. Semin Immunol 2003; 15:271-276.
21. De la Rosa G, Longo N, Rodriguez-Fernandez JL, Puig-Kroger A, Pineda A, Corbi AL, et al. Migration of human blood dendritic cells across endothelial cell monolayers: adhesion molecules and chemokines involved in subsetspecific transmigration. J Leukoc Biol 2003; 73:639-649.
22. Penna G, Vulcano M, Sozzani S, Adorini L. Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 2002; 63:1164-1171. (Pubitemid 36025991)
23. Dopheide JF, Sester U, Schlitt A, Horstick G, Rupprecht HJ, Munzel T, et al. Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro. Coron Artery Dis 2007; 18:523-531.
24. Ranjit S, Dazhu L, Qiutang Z, Yibo F, Yushu L, Xiang W, et al. Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina. Int J Cardiol 2004; 97:551-555.
25. Wang L, Li D, Yang K, Hu Y, Zeng Q. Toll-like receptor-4 and mitogenactivated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome. Immunology 2008; 125:122-130.
26. Van Vré EA, Bult H, Hoymans VY, Van Tendeloo VF, Vrints CJ, Bosmans JM. Human C-reactive protein activates monocyte-derived dendritic cells and induces dendritic cell-mediated T-cell activation. Arterioscler Thromb Vasc Biol 2008; 28:511-518.
27. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent by stander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006; 113:2135-2150.